Federica Cavallo

24PUBLICATIONS
138CO-AUTHORS
Haematological tumoursPredictive and prognostic markersRadiation therapyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (24)

|Aug 12, 2026
Increased risk of secondary malignancies after autologous transplantation in R/R follicular lymphoma: Long-term results from FIL-FLAZ12 Phase III trial.

|Jul 24, 2026
Molecular biomarkers as key determinants of outcome in mantle cell lymphoma: results from the FIL V-RBAC trial.

|Jun 25, 2026
Renoir phase III Rituximab-Lenalidomide vs Rituximab as Maintenance Treatment in Relapsed/Refractory Follicular Lymphoma.

|May 04, 2026
Dissecting minimal residual disease dynamics to improve outcome prediction in mantle cell lymphoma: Data from the Fondazione Italiana Linfomi (FIL)-MCL0208 clinical trial.

|Mar 19, 2026
Quantitative MYD88 L265P and flow cytometry levels for outcome determination in IgM gammopathies: the SAL-TO study.

Irene Dogliotti, Cristina Jiménez, Veronica Peri

|Jan 22, 2026
Clinical impact of immunoglobulin heavy chain repertoire in mantle cell lymphoma: A study from the Fondazione Italiana Linfomi (FIL) Phase III MCL0208 trial.

Simone Ragaini, Elisa Genuardi, Beatrice Alessandria

Pageof 4

Frequent Collaborators

9 joint publications

Simone Ferrero

6 joint publications

Vittorio Ruggero Zilioli

6 joint publications

Simone Ragaini

5 joint publications

Luca Arcaini